What Does a Pulse Oximeter Cost?

Clinical-grade SpO₂ monitoring spans from under $100 for a prescription fingertip unit to more than $8,000 for a full-featured bedside system — and sensor consumables can eclipse hardware costs within two years.

Pulse oximeter pricing is highly segmented by form factor, signal-processing technology, and sensor ecosystem. A spot-check clinical fingertip device (e.g., Nonin Onyx Vantage 9590) lists in the $200–$350 range at medical supply distributors. Handheld units such as the Nonin PalmSAT 2500 run roughly $300–$900. Bedside/tabletop continuous monitors from Masimo, Nellcor (Medtronic), or Nonin typically carry new list prices of $1,000–$4,000+, while advanced multi-parameter systems (e.g., Masimo Radical-7 or Root platform) can exceed $6,000–$8,000 before sensor accessories. Masimo and Nellcor do not publish institutional list prices online; exact figures require a quote request. MedSource does not yet have aggregate submitted-quote data for this category — pricing will be updated as quotes accrue. All figures below are derived from distributor catalogs, used-equipment markets, published GSA/VA schedule principles, and peer-reviewed cost literature.

---

What the Typical Range Is

Form Factor	Typical New List Price	Notes
Clinical fingertip (Rx-grade)	$80 – $350	e.g., Nonin Onyx Vantage 9590
Handheld spot-check	$300 – $900	e.g., Nonin PalmSAT 2500, Nellcor PM10N
Tabletop/bedside continuous	$1,000 – $4,000	e.g., Masimo Rad-8, Nellcor N-600x
Advanced multi-parameter (Rainbow/SET platforms)	$4,000 – $8,500+	Adds hemoglobin, carboxyhemoglobin, RRp
Refurbished tabletop	$160 – $1,500	Varies by brand, age, warranty

In a 2023 survey across three hospitals at an academic medical center, new and used prices were found for nearly 90% of 5,079 devices, with the average equipment cost to replace pulse oximetry hardware running approximately $15,704 per bed — a figure that aggregates fingertip probes, handheld units, bedside monitors, and integrated rack systems across a full ICU/ward deployment.

The same Duke University study found total replacement and integration costs of $14.2–$17.4 million for a three-hospital system, with some device life cycles extending beyond 18 years. That longevity data is useful at the capital-planning stage: a well-maintained bedside monitor should yield a 10–15 year useful life.

---

What Pushes Price Up — Features, Certifications, Support Tier

Signal-processing technology: Masimo SET® technology is available on a wide variety of multi-parameter, bedside, handheld, and fingertip pulse oximeters , and devices licensed under that platform command a premium over commodity alternatives. Beyond SpO₂ and pulse rate, Masimo SET® products also measure perfusion index (Pi), and advanced Rainbow® multi-wavelength sensors (4+ LEDs) add parameters such as hemoglobin concentration and dyshemoglobin levels. Each added Rainbow parameter typically adds $500–$1,500 to hardware cost and requires proprietary sensors.

Regulatory compliance tier: Clinical pulse oximeters are Class II devices regulated under 21 CFR 870.2700 , requiring FDA 510(k) clearance. Devices that also carry ISO 80601-2-61 and IEC 60601-1 / IEC 60601-1-2 compliance command higher prices than OTC-only variants — and that compliance is required for clinical environments. Mandatory standards include IEC 60601-1:2005/AC:2012 for general safety and IEC 60601-1-2:2014 for electromagnetic disturbance requirements.

Connectivity and EHR integration: The latest bedside monitors are highly "connected," featuring Bluetooth, Wi-Fi, and integration with Electronic Health Records (EHR) to facilitate automated alerts and centralized data management. Expect a $300–$800 premium for a networked unit versus a standalone unit of equivalent SpO₂ capability.

Neonatal/pediatric-rated: Neonatal sensors and pediatric accuracy ratings (±3% under motion) involve separate clinical validation and add cost. Expect 20–40% above equivalent adult units.

Multi-patient vs. single-patient use: Bedside monitors rated for continuous multi-patient use with reusable sensors command the highest per-unit costs but lower per-patient consumable costs in high-turnover settings like the ED or PACU.

---

What Pushes Price Down — Refurbished, Older Generation, Lease, GPO Contracts

Refurbished market: Refurbished dealers such as Soma Technology offer pulse oximeters at up to 50% below OEM prices with equivalent service and warranty, with inventory spanning handheld, tabletop, and wearable options from brands including Medtronic, Masimo, and Nellcor. Verify that refurbished units carry a documented calibration certificate and have not exceeded the manufacturer's recommended service life.

Prior generation hardware: A Masimo Rad-8 (current generation, ~$2,000–$2,800 new) versus an older Rad-5 will deliver similar basic SpO₂/PR accuracy at a significantly lower used-market price, often $99–$500 on surplus platforms. Trade-off: no Rainbow parameters, limited or no EHR connectivity.

GPO and VA/GSA schedule purchasing: Hospitals and federally eligible entities purchasing through GPO vehicles (Premier, Vizient, HealthTrust) or the VA Federal Supply Schedule typically unlock volume pricing that is 15–35% below standard commercial list. The Federal Supply Schedule program provides agencies with a simplified process for obtaining commercial supplies at prices associated with volume buying. Non-federal healthcare entities cannot access GSA schedules directly but can leverage analogous GPO agreements.

Leasing/per-use models: Some vendors offer capital equipment lease arrangements (36–60 month terms) or per-patient-day bundled pricing that includes hardware, sensors, and service. These models shift capital expense to operating expense — favorable for ASCs and smaller clinics managing CAPEX budgets.

Commodity fingertip units for spot-check only: For low-acuity applications (e.g., pre-op triage in a clinic waiting room), FDA 510(k)-cleared fingertip units from Contec (CMS-50D family) and similar manufacturers list under $100 per unit at distributor pricing. The FDA distinguishes between prescription pulse oximeters, which are clinically tested and intended for medical use, and over-the-counter versions, which may lack the same accuracy and are mainly for wellness purposes. Only Rx-grade, 510(k)-cleared devices should be used for clinical decision-making.

---

Hidden Costs — Install, Training, Calibration, Consumables, Service Contracts

Sensors are the largest long-term cost driver. Major brands operate proprietary sensor ecosystems: Masimo LNOP/LNCS connectors are not interchangeable with Nellcor OxiMax sensors. For bedside continuous monitoring, single-patient-use disposable sensors run approximately $5–$20 each depending on site (neonatal adhesive sensors are at the high end). A 30-bed ICU running a sensor-per-patient-day model can accumulate $55,000–$220,000 in sensor spend annually — often exceeding the hardware purchase price within 18–24 months.

Integration costs: Additional costs for integrating devices into hospital systems are projected to be between $3.25 and $6.5 million at a large academic medical center with three hospitals. Even for smaller deployments, biomedical engineering time for software setup, network registration, and nurse-call integration should be budgeted at 2–4 hours per unit.

Service contracts: Expect annual service contract pricing at 8–12% of purchase price for full-coverage agreements. Masimo and Nellcor service contracts are typically non-negotiable on the base terms but can be bundled with sensor agreements for a flat per-unit annual fee.

Calibration and preventive maintenance: Pulse oximeters are not typically calibrated in the field (they are factory-calibrated). However, AAMI and The Joint Commission recommend periodic functional verification using a calibrated SpO₂ simulator. Biomed department time cost should be factored at approximately 30 minutes per unit annually.

Training: Vendor-supplied applications training is often included for tabletop and bedside units. Budget for 1–2 hours per nursing unit for initial rollout; recurring competency checks should be factored as internal staff time.

---

How to Negotiate — Concrete Tactics

1. Separate hardware from sensor contracts. Vendors prefer bundled deals. Negotiating hardware price independently — before committing to sensor exclusivity — can recover 10–20% on the equipment side. Request sensor pricing per-unit locked for 3–5 years in writing.

2. Benchmark against the secondary market. Obtain quotes for equivalent refurbished units from dealers like Soma Technology or PartsSource. Use those figures as leverage: a refurbished Masimo Rad-8 at $700 gives you a floor for negotiating new-unit pricing at $1,400–$1,800 rather than full list.

3. Use GPO contracts as a floor, not a ceiling. GPO pricing is a pre-negotiated baseline. Vendors will often discount further for large volume, multi-site orders, or when you are switching from a competitor's platform.

4. Request a fleet audit and staged refresh. Some device life cycles extend beyond 18 years , meaning a full same-day replacement is rarely necessary. Negotiating a phased refresh (e.g., replacing highest-acuity units first over 3 years) reduces upfront capital commitment and gives vendors incentive to price aggressively for guaranteed future volume.

5. Time the purchase to fiscal year-end. Masimo, Medtronic/Nellcor, and Nonin all operate on December 31 or June 30 fiscal years. Significant additional discounts (5–12%) are often available in the final 6 weeks of each fiscal quarter.

6. Require a loaner or demo unit. A 30-day in-facility trial with a full ICU complement costs the vendor nothing in marginal hardware cost and gives your biomed and nursing staff real-world performance data before commitment.

---

When the Price Feels Off — Red Flags

• No FDA 510(k) clearance number. Any device presented for clinical use without a verifiable 510(k) listing in FDA's CDRH database (accessible at accessdata.fda.gov) should be disqualified immediately. Clinical oximeters are regulated as Class II devices under 21 CFR 870.2700.

• SpO₂ accuracy claims better than ±2% Arms without supporting clinical data. Pulse oximeters are considered accurate with a measure of oxygen saturation levels of ±2% of set standards. Claims of ±1% accuracy without peer-reviewed desaturation study data should be treated with skepticism.

• Missing IEC 60601-1 and ISO 80601-2-61 compliance documentation. ISO 80601-2-61:2011 sets particular requirements for basic safety and essential performance of pulse oximeter equipment. If a vendor cannot produce a Declaration of Conformity to this standard, the device is not suitable for a clinical environment.

• Sensor pricing withheld until post-purchase. If a vendor refuses to provide sensor pricing before contract execution, it indicates the sensor margin will substantially offset any hardware discount. Walk away or insist on a signed sensor pricing addendum.

• Unusually low pricing on "new" branded equipment (e.g., Masimo or Nellcor units at 70%+ below known market value). This is the primary indicator of counterfeit or gray-market imports that may not meet U.S. regulatory requirements.

• No service history or calibration records on refurbished units. Legitimate refurbishers provide a service report, parts list, and functional test results. A unit sold "as-is" without documentation carries unknown failure risk and should be priced accordingly.

---

Sources

1. FDA — Pulse Oximeters – Premarket Notification Submissions [510(k)s]: Guidance for Industry and FDA Staff. Regulatory classification under 21 CFR 870.2700 (Class II). accessdata.fda.gov

2. Dempsey K, Matos J, et al. — "The High Price of Equity in Pulse Oximetry: A Cost Evaluation and Need for Interim Solutions." PLOS Digital Health, September 2024. Primary source for per-bed fleet replacement cost data. doi.org/10.1371/journal.pdig.0000372

3. FDA Executive Summary — Review of Pulse Oximeters and Associated Accessories, including discussion of ISO 80601-2-61 and IEC 60601-1 standard requirements for clinical-grade devices. fda.gov/media/162709/download

4. GSA/FAR Subpart 8.4 — Federal Supply Schedule program terms, applicable to VA and federally eligible healthcare purchasers. acquisition.gov/far/subpart-8.4

---

Prices cited reflect publicly available distributor list prices and secondary-market data as of Q2 2025. Institutional negotiated pricing will differ. This article will be updated as MedSource collects submitted quote data for this category.